We're looking for Senior Medical Safety Officer/Safety Manager to join Tigermed team in Japan. If you're passionate about safety activities for clients from clinical trial to post-marketing, we want to hear from you. Feel free to contact Jocelyn Liu or share this post with your network. #hiring #hiring #hiring
关于我们
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.
- 所属行业
- 制药业
- 规模
- 5,001-10,000 人
- 总部
- Hangzhou,Zhejiang
- 类型
- 上市公司
- 创立
- 2004
- 领域
- BE study Generic Drugs Quality Consistency Evaluation、Preclinical/CMC/Bioanalytical、Clinical related services、Regulatory Affairs、Clinical trial---Phase I to IV & NIS和MART&Oversea clinical service
地点
-
主要
No.19 Jugong Road, Binjiang District
F18, Building A – Shengda Science Park
CN,Zhejiang,Hangzhou,310053
-
Changning District, Shanghai,P.R.China
Fl.16,999 West Zhongshan Road,
CN,Shanghai,Shanghai,200051
-
No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China
Room 808,Union Mansion
CN,Beijing,Beijing,100020
Tigermed员工
动态
-
During the #ESMO 2024 conference, Tigermed experts from Europe, Asia-Pacific, the Americas, and other regions gathered in Barcelona. They showcased Tigermed's extensive expertise in #antitumor drug clinical research to an international audience at booth #434. Tigermed also hosted an Exclusive Reception entitled "Leading the Next Wave in Oncology Innovation," attracting a distinguished assembly of global #oncology experts and leaders from pioneering enterprises. We are deeply grateful for everyone’s passion to interact with Tigermed at #ESMO 2024, and it is all of you that empowers what we do possible.
-
We are thrilled to be invited and to be part of the Healthcare Collaboration events in Southeast Asia, organized by GL Capital Group, which provided an outstanding opportunity to discuss with local partners and stakeholders on how our global platform to enable healthcare innovation in the region. Mr. Hao Wu, Co-President of Tigermed, Mr. Hua Shao, Vice President and Head of Tigermed Southeast Asia & Latin America, and other colleagues from Indonesia and Singapore attended the events and showcased what Tigermed can support to drive innovation and improve sustainable healthcare in Southeast Asia. #southeastasia #tigermed #singapore #indonesia #clinicaltrials
-
We are proud to announce the collaboration and MOU (Memorandum of Understanding) signing ceremony with Purpose Africa last Friday in Hangzhou, China, which represents a new direction in China-Africa collaboration in clinical research and digital platform. Its implementation will open new pathways for Africa countries to access clinical resources and higher-quality pharmaceuticals products from China, and will be a step forward in our joint efforts to advance global clinical trials. #clinicaltrials #china #africa #clinicalresearch
-
+1
-
New page exploration in action with #Tigermed We have flexible service capabilities with a global network of trusted medical and clinical translators, covering over 80 #languages across locations where clinical research take place. We established a strict translation workflow and quality assurance system to provide #timely and #accurate translation and interpretation services. It covers all #medical fields including drugs, medical devices, regulations, biological products, animal health, vaccines, health nutrition, cosmetics, training and other products or materials. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/g9Q5Kd7W
-
HANGZHOU, China, Aug. 28, 2024 -- Hangzhou Tigermed Consulting Co., Ltd. (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its interim results for the first half of 2024, ended June 30, 2024 (the "Reporting Period"). Tigermed has maintained its leading position in China's clinical service market, holding a 12.8% market share in 2023. Notably, it was the only Chinese CRO to rank among the global top 10 that year, with a global market share of 1.4%. As of June 30, 2024, Tigermed had a total of 9,348 employees across 37 countries. During the reporting period, Tigermed accumulated experience in handling over 133 multi-region clinical trials (MRCTs) and is currently executing 55 MRCT projects. Read the full press release at https://lnkd.in/gRNhcx56 #2024 #InterimResults #CRO #market
-
You’re Invited to an Exclusive Tigermed Reception at #ESMO2024! Join us for an evening of #innovation and #networking at the W Barcelona on Saturday, September 14th, 2024. At the Tigermed reception, you’ll have the opportunity to: · Discover the latest global oncology trends · Engage in thought-provoking discussions with industry leaders · Connect with top professionals in the oncology field 🗓️ Reception Agenda: 18:00 - 18:30 Check-in 18:30 - 18:35 Opening Remarks, Hao Wu, Co-President, Tigermed 18:35 - 18:50 Keynote "Navigating the Future of Oncology: Capitalizing on Cutting-Edge Advancements" , Britney Winterberger, Senior Clinical Project Director, Tigermed 18:50 - 19:05 Keynote "Licensing Trends in China: Driving Pharma Innovation and Regulatory Evolution" , Xiaohua Zhang, Senior Regulatory Affairs Director, Tigermed 19:05 - 21:00 Reception | Networking Secure your spot now: https://lnkd.in/gtgrhR6R We look forward to seeing you there!
-
We were honored to welcome Executive Manager of ABRACRO – Fernando de Rezende Francisco visiting Tigermed Shanghai office yesterday and had in-depth discussion on how to build the bridge between China and Brazil for enhancing collaborations on clinical research, digital innovation and more. #tigermed #clinicaltrials #clinicalresearch #brazil #healthcare #cro
-
Join Us for Tigermed’s Exclusive Reception at ESMO 2024! We are delighted to invite you to an exclusive reception hosted by Tigermed at the stunning W Barcelona during the ESMO Congress 2024. · Date: Saturday, September 14th, 2024 · Time: 18:00 - 21:00 CEST · Venue: W Barcelona, 1 Plaça de la Rosa dels Vents, E Floor, Breeze Room, 08039 Barcelona, Spain This exceptional event offers a perfect blend of insightful presentations and valuable networking opportunities. Experience the latest global oncology trends, engage in thought-provoking discussions with industry leaders, and connect with top professionals in the field. Don't miss out on this memorable evening! Secure your spot by registering Here. We look forward to seeing you there! #Reception #ESMO #Oncology #Innovation
-
#ESMO 2024 will be held in Barcelona, Spain from 13-17 September 2024, disseminating the latest #cutting-edge data, providing high quality education and excellent #networking opportunities. Don't miss this unique chance to stay at the forefront of #oncology and contribute to the fight against #cancer. We look forward to welcoming you at Tigermed Booth 434!